Aclaris Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since January 2024 -- Data Talk

Dow Jones
01/27

Aclaris Therapeutics, Inc. (ACRS) is currently at $3.82, down $0.68 or 15.11%

 

--Would be lowest close since Jan. 16, 2026, when it closed at $2.62

--On pace for largest percent decrease since Jan. 10, 2024, when it fell 21.48%

--Currently down three of the past four days

--Currently down two consecutive days; down 15.67% over this period

--Worst two day stretch since the two days ending Nov. 15, 2024, when it fell 15.98%

--Up 26.91% month-to-date; on pace for best month since Oct. 2025, when it rose 32.63%

--Up 26.91% year-to-date

--Down 88.42% from its all-time closing high of $32.99 on April 17, 2017

--Up 55.92% from 52 weeks ago (Jan. 27, 2025), when it closed at $2.45

--Down 15.67% from its 52-week closing high of $4.53 on Jan. 22, 2026

--Up 253.7% from its 52-week closing low of $1.08 on April 10, 2025

--Traded as low as $3.77

--Down 16.22% at today's intraday low; largest intraday percent decrease since Nov. 20, 2024, when it fell as much as 20.04%

 

All data as of 2:26:27 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

January 26, 2026 14:29 ET (19:29 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10